Donald Lloyd-Jones
Lloyd, Clem J.
Lloyd, Clement John, 1939-
Lloyd, Clement John 1939-2001
Lloyd, C. J. (Clement John), 1939-2001
VIAF ID: 110118699 (Personal)
Permalink: http://viaf.org/viaf/110118699
Preferred Forms
- 100 0 _ ‡a Donald Lloyd-Jones
-
-
-
- 100 1 _ ‡a Lloyd, Clem J.
- 100 1 _ ‡a Lloyd, Clem J.
-
- 100 1 _ ‡a Lloyd, Clement John ‡d 1939-
- 100 1 _ ‡a Lloyd, Clement John, ‡d 1939-
4xx's: Alternate Name Forms (15)
Works
Title | Sources |
---|---|
Australia's national collections | |
Backroom briefings : John Curtin's war | |
Innovation and reaction : the life and death of the Federal Department of Urban and Regional Development | |
Kerr's king hit | |
The last shilling : a history of repatriation in Australia | |
Out of the wilderness | |
Parliament and the press : the Federal Parliamentary Press Gallery, 1901-88 | |
Profession, journalist : a history of the Australian Journalists' Association | |
Reference ranges of PR duration and P-wave indices in individuals free of cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). | |
Reference values of right ventricular end-diastolic area defined by ethnicity and gender in a young adult population: the CARDIA study. | |
Refining Statin Prescribing in Lower-Risk Individuals: Informing Risk/Benefit Decisions | |
Relation of body mass index to late survival after valvular heart surgery | |
Reply | |
Reprint of: Positive Psychological Well-Being and Cardiovascular Disease: JACC Health Promotion Series | |
Response to Brachial Pulse Pressure and Cardiovascular Risk | |
Response to Letter Regarding Article, "Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate". | |
Risk stratification for arrhythmic sudden cardiac death: identifying the roadblocks | |
The Role of Biomarkers and Genetics in Peripheral Arterial Disease | |
The role of latency period in quality management for free-breathing coronary wall MRI. | |
Screening for cardiovascular risk in asymptomatic patients | |
Serial measures of cardiac troponin T levels by a highly sensitive assay and incident atrial fibrillation in a prospective cohort of ambulatory older adults | |
Sex and Race Differences in Lifetime Risk of Heart Failure with Preserved Ejection Fraction and Heart Failure with Reduced Ejection Fraction. | |
Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). | |
Short-term versus long-term risk for coronary artery disease: implications for lipid guidelines | |
Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults | |
Simulation of Daily Snapshot Rhythm Monitoring to Identify Atrial Fibrillation in Continuously Monitored Patients with Stroke Risk Factors | |
Social avoidance and long-term risk for cardiovascular disease death in healthy men: the Western Electric study. | |
Statins, risk assessment, and the new American prevention guidelines | |
Status of cardiovascular health in US adults: prevalence estimates from the National Health and Nutrition Examination Surveys (NHANES) 2003-2008. | |
Strategies for treating lipids for prevention: risk stratification models with and without imaging | |
Sudden Cardiac Death Risk Distribution in the United States Population (from NHANES, 2005 to 2012) | |
Systematic examination of a heart failure risk prediction tool: The pooled cohort equations to prevent heart failure | |
Systematic Examination of the Updated Framingham Heart Study General Cardiovascular Risk Profile | |
Systolic blood pressure and incident heart failure in the elderly. The Cardiovascular Health Study and the Health, Ageing and Body Composition Study | |
T1 contrast in the myocardium and blood pool: a quantitative assessment of gadopentetate dimeglumine and gadofosveset trisodium at 1.5 and 3 T. | |
Temporal Changes in Resting Heart Rate, Left Ventricular Dysfunction, Heart Failure and Cardiovascular Disease: CARDIA Study | |
Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk | |
Traditional Risk Factors Versus Biomarkers for Prediction of Secondary Events in Patients With Stable Coronary Heart Disease: From the Heart and Soul Study | |
Treatment and Control of Hypertension in the Community | |
Tree-structured analysis of treatment effects with large observational data | |
Trends in heart failure-related cardiovascular mortality in rural versus urban United States counties, 2011-2018: A cross-sectional study | |
Trends in Levels of Lipids and Apolipoprotein B in US Youths Aged 6 to 19 Years, 1999-2016 | |
Trends in Racial/Ethnic Disparities in Cardiovascular Health Among US Adults From 1999-2012. | |
Trends in the Prevalence of Self-reported Heart Failure by Race/Ethnicity and Age From 2001 to 2016 | |
Trends in vascular risk factor treatment and control in US stroke survivors: the National Health and Nutrition Examination Surveys (1999-2010). | |
Unsupervised exercise and mobility loss in peripheral artery disease: a randomized controlled trial | |
The use of group sequential, information-based sample size re-estimation in the design of the PRIMO study of chronic kidney disease | |
Use of Long-term Cumulative Blood Pressure in Cardiovascular Risk Prediction Models | |
Usefulness of Left Ventricular Mass and Geometry for Determining 10-Year Prediction of Cardiovascular Disease in Adults Aged >65 Years (from the Cardiovascular Health Study). | |
Usefulness of the TIMI Risk Index in Predicting Short- and Long-Term Mortality in Patients With Acute Coronary Syndromes | |
Using a multiplier of 10-year cardiovascular mortality underestimates cardiovascular risk in younger individuals and women | |
Using Machine Learning to Integrate Socio-Behavioral Factors in Predicting Cardiovascular-Related Mortality Risk | |
USPSTF Recommendations for Assessment of Cardiovascular Risk With Nontraditional Risk Factors: Finding the Right Tests for the Right Patients | |
Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department | |
Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations | |
Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association | |
Vascular basis for the treatment of myocardial ischemia study: trial design and baseline characteristics | |
Vascular health across young adulthood and midlife cerebral autoregulation, gait, and cognition | |
Ventricular Ectopy and Arrhythmia Characteristics for Persons Living with HIV and Uninfected Controls | |
Visit-to-Visit Blood Pressure Variability in Young Adulthood and Hippocampal Volume and Integrity at Middle Age: The CARDIA Study | |
Vitamin D Receptor Activation and Left Ventricular Hypertrophy in Advanced Kidney Disease | |
Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. | |
Vulnerable blood in high risk vascular patients: study design and methods | |
White blood cell count in young adulthood and coronary artery calcification in early middle age: coronary artery risk development in young adults | |
Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factor levels in the ATP-III risk assessment tool | |
Whole-genome sequencing association analysis of quantitative red blood cell phenotypes: The NHLBI TOPMed program | |
Widening Rural-Urban Cardiometabolic Mortality Gap in the United States, 1999 to 2017 | |
Workplace wellness recognition for optimizing workplace health: a presidential advisory from the American Heart Association | |
Yield of screening for coronary artery calcium in early middle-age adults based on the 10-year Framingham Risk Score: the CARDIA study | |
প্রত্যুত্তর |